Sensimed AG completes series C financing of CHF 25M with Vertex Venture Singapore
PRESS RELEASE - Sensimed AG announced today the finalization of its Series C financing round for a total of CHF 25 million. An initial closing of CHF 17M of this round led by current investors Wellington Partners, Agate Medical Investments and Vinci Capital/Renaissance PME was done last October, and the remaining CHF 8M has been subscribed by Vertex Venture Management, a top tier investor based in Singapore.
SENSIMED Triggerfish clinical outcomes to be presented at ARVO congress 2013
PRESS RELEASE - Sensimed AG, announced today that 10 scientific publications reporting outcomes of clinical studies investigating the use of SENSIMED Triggerfish® will be presented at ARVO 2013. The company developed the SENSIMED Triggerfish®, a revolutionary contact lens for the continuous recording of the 24-hour intraocular pressure (IOP) pattern to facilitate the management of glaucoma.
Sensimed to actively participate in the coming Glaucoma 360 Conference and at the American Glaucoma Society in the USA
PRESS RELEASE - Sensimed AG, announced today that the company will participate in two major glaucoma meetings taking place in San Francisco in February 2013. Sensimed is proud to present its breakthrough technology at the Glaucoma 360 New Horizons Forum being held on Friday, February 1st, 2013 at the Palace Hotel, in San Francisco.In addition, the company will present 4 scientific abstracts at the upcoming American Glaucoma Society (AGS) meeting from February 28th to March 3rd 2013 in San Francisco.
Sensimed AG receives a new reimbursement code in the USA for monitoring of intraocular pressure
PRESS RELEASE - Sensimed AG, announced today that the American Medical Association (AMA) has approved a new Current Procedural Terminology (CPT®) code for monitoring of IOP for 24 hours or longer.
Sensimed will be presenting at the HealthStartup Europe in London on December 12th, 2012.
PRESS RELEASE - The HealthStartup event with the theme on “health data integration”, will gather a select group of approximately 100 investors, entrepreneurs and healthcare decision makers. The mission of HealthStartup is to enhance synergy between start-up and investors by creating panel discussions with topic experts.